DEVICE CATEGORY · OVG
Magnetic Cell Selection System For Cd34+ Cells From Hpc-Apheresis Used In Treatment Of Acute Myeloid Leukemia (Aml)
For processing hematopoietic progenitor cells-apheresis (HPC-A) from an HLA-identical donor to obtain a CD34 positive cell enriched population that will provide for hematopoietic reconstitution following a myeloablative preparative regimen without the need for additional graft-vs-host disease (GVHD) prophylaxis.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|
No records match this search
Try a device name, company name or regulatory identifier.
Source information
Follow the FDA links to view the original records.